21 C.F.R. § 170.35

Affirmation of generally recognized as safe (GRAS) status

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

(a) The Commissioner, on his own initiative, may affirm that a substance that directly or indirectly becomes a component of food is GRAS under the conditions of its intended use.

(b)(1) If the Commissioner proposes on his own initiative that a substance is entitled to affirmation as GRAS under the conditions of its intended use, he will place all of the data and information on which he relies on public file in the office of the Dockets Management Staff and will publish in the Federal Register a notice giving the name of the substance, its proposed uses, and any limitations proposed for purposes other than safety.

(2) The Federal Register notice will allow a period of 60 days during which any interested person may review the data and information and/or file comments with the Dockets Management Staff. Copies of all comments received shall be made available for examination in the Dockets Management Staff's office.

(3) The Commissioner will evaluate all comments received. If he concludes that there is convincing evidence that the substance is GRAS under the conditions of its intended use as described in § 170.30, he will publish a notice in the Federal Register listing the GRAS conditions of use of the substance in part 184 or part 186 of this chapter, as appropriate.

(4) If, after evaluation of the comments, the Commissioner concludes that there is a lack of convincing evidence that a substance is GRAS under the conditions of its intended use and that it should be considered a food additive subject to section 409 of the Federal Food, Drug, and Cosmetic Act, he shall publish a notice thereof in the Federal Register in accordance with § 170.38.

(Information collection requirements were approved by the Office of Management and Budget under control number 0910-0132) [42 FR 14488, Mar. 15, 1977, as amended at 50 FR 7492, Feb. 22, 1985; 50 FR 16668, Apr. 26, 1985; 53 FR 16547, May 10, 1988; 62 FR 40599, July 29, 1997; 65 FR 51762, Aug. 25, 2000; 81 FR 55048, Aug. 17, 2016; 88 FR 17718, Mar. 24, 2023]
Notes of Decisions
Cited in 4 cases (2 in the last 5 years), 1992–2021 · leading case: Uri Marrache v. Bacardi U.S.A., Inc., 17 F.4th 1084 (11th Cir. 2021).
Uri Marrache v. Bacardi U.S.A., Inc., 17 F.4th 1084 (11th Cir. 2021). “§ 348 (b)–(d); 21 C.F.R. §§ 170.35 , 170.38, 171.100(a); see also Nem- phos v.”
United States v. 45/194 Kg. Drums of Pure Vegetable Oil, Efamol, Ltd., Claimant-Appellant, 961 F.2d 808 (9th Cir. 1992). · cites it 2× “section 171, or an affirmation petition in accordance with 21 C.F.R. section 170.35. Efamol informed the FDA it would no longer export EPO to the United States.”
Ctr. for Food Saf. v. Burwell, 126 F. Supp. 3d 114 (D.D.C. 2015). “See 21 C.F.R. § 170.35 (2011). FDA would then proceed by comprehensively reviewing this scientific data, publishing a notice in the Federal Register for comment, and drafting an explanation of FDA’s GRAS determination.”
Ctr. for Food Saf. v. Price (S.D.N.Y. 2021). “” 21 C.F.R. § 170.35 (c)(1) (reserved by 81 Fed.”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.